STAAR Surgical authorizes USD 50 million share repurchase program
Bitget2026/09/24 20:01- STAAR Surgical’s board, at a regularly scheduled meeting, authorized a share repurchase program of up to USD 50 million.
- Buybacks may be executed in the open market, via private transactions, structured agreements, block trades, or Rule 10b5-1 plans.
- Repurchase timing, price, and volume will be set at management’s discretion; the program can be modified, suspended, or ended.
- Program is expected to run for 12 months; funding planned from free cash flow and cash on hand.
- As of July 3, 2026, STAAR reported USD 181.5 million in cash and investments, no debt; about 50,100,000 shares outstanding as of Aug. 7, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote